| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nkarta, Inc. | Director | Stock Option (right to buy) | 46,000 | 05 Jun 2025 | Direct | ||
| LENZ Therapeutics, Inc. | Director | Stock Option (right to buy) | 13,500 | 11 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 11 Jun 2025, 17:45 |
| NKTX | Nkarta, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 16:02 |
| NKTX | Nkarta, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:10 |
| LENZ | LENZ Therapeutics, Inc. | 21 Mar 2024 | 1 | $0 | 4 | Director | 25 Mar 2024, 20:40 |
| LENZ | LENZ Therapeutics, Inc. | 21 Mar 2024 | 0 | $0 | 3 | Director | 25 Mar 2024, 20:38 |
| NKTX | Nkarta, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 16:04 |
| NKTX | Nkarta, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:09 |
| NKTX | Nkarta, Inc. | 13 Jun 2021 | 1 | $0 | 4 | Director | 15 Jun 2021, 10:26 |